
IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. (IDXX) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
idxx · pe ratio · data through Jun 10, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Medical - Diagnostics & Research · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
IDEXX Laboratories, Inc.You IDXX | $44.3B | N/A | — | — |
Agilent Technologies, Inc. A | $37.5B | 31.79x | -41.8% | $4.60 |
Alnylam Pharmaceuticals, Inc. ALNY | $39.0B | 166.04x | +203.9% | $2.39 |
argenx SE ARGX | $54.6B | 39.90x | -27.0% | $21.08 |
Becton, Dickinson and Company BDX | $54.4B | 25.13x | -54.0% | $5.85 |
Cardinal Health, Inc. CAH | $47.9B | 25.94x | -52.5% | $6.48 |
Cencora, Inc. COR | $53.3B | 38.98x | -28.7% | $8.02 |
Industry Average 6 peers with valid PE | — | 54.63x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for IDEXX Laboratories, Inc. (IDXX) measures how much investors pay for each dollar of the company's trailing earnings. IDXX's current PE ratio of N/A is calculated by dividing its stock price of $561.17 by its TTM earnings per share of —.
Frequently asked questions
IDXX pe ratio · 6 questionsIDXX's current PE ratio is N/A as of 2026-06-10, based on a stock price of $561.17 and TTM EPS of —. Data sourced from Financial Modeling Prep via IDXX's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · IDEXX Laboratories, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-10